Helus Pharma Inc. (HELP) Discusses Clinical Pipeline and Phase 3 Strategies for Novel Serotonergic Agonists in Mental Health Transcript
Seeking Alpha·2026-10-22 05:43
Welcome to the Helus Pharma Investor presentation. Before we get started, I would like to remind everyone that certain statements in this presentation are forward-looking statements and are prospective in nature. In preparing these forward-looking statements, several assumptions were made by Helus and there are risks and actual results obtained by the company will differ materially from these statements. The company cannot guarantee any forward-looking statements will materialize, and you are cautioned not ...